MoneyWorks4Me

The company witnessed a 9.82% growth in the revenue at Rs. 5516.90 millions for the quarter ended June 2025 as compared to Rs. 5023.80 millions during the year-ago period.Profit saw a slight increase of 14.42%to Rs. 339.60  millions from Rs. 296.80 millions.Operating profit for the quarter ended June 2025 rose to 695.20 millions as compared to 581.80 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 5516.90 5023.80 9.82 5516.90 5023.80 9.82 20792.10 21327.90 -2.51
Other Income 73.70 73.80 -0.14 73.70 73.80 -0.14 224.00 300.70 -25.51
PBIDT 695.20 581.80 19.49 695.20 581.80 19.49 2245.70 2615.90 -14.15
Interest 42.30 21.50 96.74 42.30 21.50 96.74 147.60 161.00 -8.32
PBDT 652.90 560.30 16.53 652.90 560.30 16.53 2098.10 2454.90 -14.53
Depreciation 197.50 168.00 17.56 197.50 168.00 17.56 719.20 628.50 14.43
PBT 455.40 392.30 16.08 455.40 392.30 16.08 1378.90 1826.40 -24.50
TAX 115.80 95.50 21.26 115.80 95.50 21.26 368.90 472.20 -21.88
Deferred Tax 10.90 7.80 39.74 10.90 7.80 39.74 121.50 102.10 19.00
PAT 339.60 296.80 14.42 339.60 296.80 14.42 1010.00 1354.20 -25.42
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 12.60 11.58 8.81 12.60 11.58 8.81 10.80 12.27 -11.94
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..